https://sciencedaily.com/releases/2024/10/241001132939.htm
Structure of a eukaryotic CRISPR-Cas homolog, Fanzor2, shows its promise for gene editing |...
Scientists have revealed how Fanzor2's divergence from bacterial ancestors may make it a useful tool for future genomic engineering endeavors.